Phase I dose-finding and pharmacokinetic study of a combination of elisidepsin (E) and erlotinib (T) in patients (pts) with advanced solid tumors.
暂无分享,去创建一个
R. Rosell | U. Swami | S. Goel | I. Chaudhary | E. Carcereny | T. Morán | Santiago Viteri Ramírez | C. Bugés | M. Ghalib | C. Coronado | Jorge Luis Iglesias Dios | Y. Hou | J. Alcântara | B. Miguel | Yijuan Hou